Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC
Status:
Terminated
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The aim of the study if to determine if Iressa can prolong the period of time without any
disease worsening (Time to progression) in patients previously treated with combined therapy
such as surgery and chemotherapy with or without radiotherapy or chemotherapy and
radiotherapy